Navigation Links
New Data Demonstrate Longer-Term Safety Profile of Esbriet®
Date:9/26/2011

ng the third quarter of 2012.

Since 2008, pirfenidone has been marketed in Japan as Pirespa® by Shionogi & Co. Ltd.

Pirfenidone is still under investigation for the treatment of IPF in the United States and has not been approved by the U.S. Food and Drug Administration for this use.

About IPF

Idiopathic pulmonary fibrosis (IPF) is a progressive, debilitating and ultimately fatal disease characterized predominantly by fibrosis (scarring) in the lungs, hindering the ability for gas exchange in the lungs. IPF is a progressive disease, meaning that over time, lung scarring and symptoms increase in severity. The median survival time from diagnosis is two to five years, with a five-year survival rate of approximately 20-40 percent, which makes IPF more rapidly lethal than many cancers, including breast, ovarian and colorectal. An estimated 30,000-35,000 new cases of IPF are diagnosed in Europe each year. Patients diagnosed with IPF are primarily between the ages of 40 and 80, with a median age of 63 years. The disease tends to affect slightly more men than women.

About InterMune

InterMune is a biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and fibrotic diseases. In pulmonology, we are focused on therapies for the treatment of idiopathic pulmonary fibrosis (IPF), a progressive and fatal lung disease. Pirfenidone, the only medicine approved worldwide for IPF, is approved for marketing by InterMune in the EU as Esbriet and is currently in a Phase 3 clinical trial in the United States. Pirfenidone is also approved for the treatment of IPF in Japan, where it is marketed by Shionogi & Co. Ltd. under the trade name Pirespa. InterMune's research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. For additional information
'/>"/>

SOURCE InterMune, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. New Study Published in New England Journal of Medicine Shows Investigational BIBF 1120 Demonstrated Positive Trend in Reducing Lung Function Loss in Idiopathic Pulmonary Fibrosis
2. Inovio Pharmaceuticals Completes PENNVAX™-B HIV Vaccine Phase I Study, Demonstrates Best-in-Class T-Cell Immune Responses
3. Germgard Lighting Demonstrates the Worlds Most Effective Hand Sterilizer to Protect Against Contagion
4. NIH-Funded Study Demonstrates That Patients Receiving New CPR Devices (ResQPOD® and ResQPump™) and Cooling Have Improved Long-Term Brain Function Following Cardiac Arrest
5. New Digital Linear Accelerator Control System Demonstrates Treatment Time Savings of Up to 30 Percent
6. Obese Patients Treated With QNEXA Demonstrated Significant Improvement in Quality of Life
7. Inovio Pharmaceuticals Demonstrates Positive Immune Responses in Phase I Clinical Trial of SynCon™ H5N1 Influenza Vaccine and Launches Multi-Subtype Influenza Vaccine Phase I
8. New Research Demonstrates High Prevalence of Sexually Transmitted Disease Trichomonas Vaginalis and Potential of New Molecular Test to Improve Detection
9. Topaz Pharmaceuticals Ivermectin Cream In Vitro Data Demonstrates Activity Against Head Lice Eggs
10. Halozymes Ultrafast Insulin Demonstrates Reduced Variability of Insulin Absorption for Type 1 Diabetes Patients Using Insulin Pumps
11. CureFAKtor Pharmaceuticals Demonstrates that Novel Focal Adhesion Kinase (FAK) Inhibitors Decrease Pancreatic Cancer Tumor Blood Flow and Reduce Blood Vessel Density
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... May 22 2015 /CNW/ - The Taskforce representing ... of all the hard work that the Minister and Health ... months. This program recognizes the needs of the thalidomide survivors, ... $75,000 a year, tax free, with annual adjustments for inflation. ... for annual payments of $100,000 based on the severity of ...
(Date:5/22/2015)... /CNW/ - More than fifty years ago, Thalidomide was approved ... expectant mothers. Tragically, Thalidomide caused serious and permanent physical and ... Support has been provided to survivors over the years from ... in 1991 and settlements from drug companies. ... to provide support, we have a clear moral obligation to ...
(Date:5/22/2015)... -- The Assistance Fund announces the addition of its ... for copay to individuals diagnosed with Melanoma. ... the Melanoma Copay Assistance Program to our portfolio of ... "With each additional program we are closer to achieving ... one is denied access to medications due to an ...
Breaking Medicine Technology:Statement from Minister Ambrose on Thalidomide 2Statement from Minister Ambrose on Thalidomide 3The Assistance Fund Adds Melanoma Assistance Program 2
... - Results Further Support the Clinical Profile of ... Survival of Patients,With Hormone Refractory Prostate Cancer (HRPC), ... therapeutics company,today announced that the primary objective of ... The study showed that even single doses of,Alpharadin ...
... involved in 10-year study, CHICAGO, Aug. 27 ... issue of the New England Journal of Medicine,found that ... gestation reduced the risk of cerebral palsy by 50 ... was,conducted in 18 centers in the U.S., including Northwestern ...
Cached Medicine Technology:Algeta Reports Positive Headline Phase II Data on Pain Palliation With Alpharadin 2Algeta Reports Positive Headline Phase II Data on Pain Palliation With Alpharadin 3Algeta Reports Positive Headline Phase II Data on Pain Palliation With Alpharadin 4National Study Shows Magnesium Sulfate Reduces Risk of Cerebral Palsy in Premature Births 2National Study Shows Magnesium Sulfate Reduces Risk of Cerebral Palsy in Premature Births 3
(Date:5/25/2015)... 26, 2015 The National Association ... a 2015-2016 inductee into its VIP Professional Woman of ... distinction for leadership in dentistry. NAPW is the nation's ... than 700,000 members and over 200 operating local chapters. ... exceptional group of professional women,” said NAPW President Star ...
(Date:5/25/2015)... York, New York (PRWEB) May 25, 2015 ... distributor of patented products, launches The Preventer, a home ... from the dangers of fire. , "House fires cost ... says Scott J. Cooper, CEO and Creative Director of ... home fire deaths result from homes that have no ...
(Date:5/25/2015)... HomeCare is proud to announce that David Allerby, Co-Founder ... Iwamoto, Co-Founder & CMO, are Finalists for the Ernst ... Greater Los Angeles. The award is presented by EY ... and a personal commitment to their communities. , “Our ... of our organization,” said Co-Founder & CEO, David Allerby, ...
(Date:5/25/2015)... May 25, 2015 Stanley Consultants ... awards for design of the wastewater treatment expansion ... project received a National Recognition Award from the American ... from ACEC – Iowa. Competitions held by the ... The $50.2 million expansion is Iowa City’s largest public ...
(Date:5/25/2015)... Rafael, CA (PRWEB) May 25, 2015 Join ... for a free two-hour instructional clinic. Irish National Player, ... campers and give them a taste of her coaching style. ... Anselmo and Novato. Camps in Novato are at Lynwood Elmentary ... , Novato High School - June 6th, 2015 - ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Inducts Dr. Laquinas Hooked, D.D.S. of General Dentist, Into its VIP Professional Woman of the Year Circle 2Health News:Home Maintenance Causes House Fires? World Patent Marketing Introduces the Best Home Patent to Prevent Fire Accidents 2Health News:Home Maintenance Causes House Fires? World Patent Marketing Introduces the Best Home Patent to Prevent Fire Accidents 3Health News:24Hr HomeCare Co-Founders Named Finalists for EY Entrepreneur of the Year 2015 Awards 2Health News:Stanley Consultants’ Expansion of Iowa City Wastewater Treatment Plant Wins National Award 2Health News:Stanley Consultants’ Expansion of Iowa City Wastewater Treatment Plant Wins National Award 3Health News:US Sports Camps and Nike Soccer Camps Offer Complimentary Instructional Clinic with Fiona's Soccer Camp 2
... has launched, dedicated to all aspiring souls with interest ... and wellness//. Founded by a personal fitness trainer turned ... inspired by her own healing process, it became the ... that educates, inspires, nurtures, and stimulates the mind, body, ...
... Thomas Jefferson University Hospital are combining efforts to determine if ... forms of migraine headaches. ,Investigators from the Jefferson ... in a blinded study to determine if closing a Patent ... allow blood to flow between the right and left sides ...
... Easter morning, two casual care support staff members allegedly assaulted ... Porirua//, New Zealand. Earlier another member of ... unit. All three are under suspension. ,Staff and ... under investigation from officials of the Capital and District Health ...
... Drug Administration (FDA) is alerting health care professionals and ... emerging// drug safety information. The broadcasts, commonly known as ... audio players. ,The service is part of ... communications concerning the safety of marketed medications when ...
... with the antiviral drug Tamiflu have the best chances of ... the World Health Organization (WHO) said on Friday. ... of international experts who met last month in Turkey to ... some countries to use steroids as well. ,"Corticosteroid ...
... exposed when thirty poor women of the fishing community, living ... The 1994 Transplant of Human Organ Act ... be allowed to donate kidneys for transplantation. However a recent ... to indicate that several leading hospitals in the state encouraged ...
Cached Medicine News:Health News:Jefferson Researchers Want to Learn If Heart Defect 'at Heart' of Some Migraines 2Health News:Mentally Ill Patients - Victims Of Assault By Their Caregivers 2Health News:FDA Announces Audio Broadcasts on Emerging Drug Safety Information 2Health News:Tamiflu Key to Treat Bird Flu, Avoid Steroids: WHO 2Health News:Kidney Trade: Curbing the Sale 2Health News:Kidney Trade: Curbing the Sale 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: